相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Eosinophilic granulomatosis with polyangiitis can manifest lacrimal and salivary glands swelling by granulomatous inflammation: a potential mimicker of IgG4-related disease
Mitsuhiro Akiyama et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study
Alice Canzian et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis
Vamsi P. Guntur et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Myocardial involvement in eosinophilic granulomatosis with polyangiitis evaluated with cardiopulmonary magnetic resonance
Jakub Lagan et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2021)
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Laurie A. Manka et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)
Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab
Naomi Tsurikisawa et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2021)
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Sharon A. Chung et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis of Test Accuracy and Benefits and Harms of Common Treatments
Jason M. Springer et al.
ACR OPEN RHEUMATOLOGY (2021)
Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry)
Roser Solans-Laque et al.
ARTHRITIS CARE & RESEARCH (2020)
STATE OF THE ART REVIEW Management of ANCA associated vasculitis
Zachary S. Wallace et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Role of Cytokines in EGPA and the Possibility of Treatment with an Anti-IL-5 Antibody
Takeo Isozaki et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
Alessandra Vultaggio et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2020)
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status
Paul A. Lyons et al.
NATURE COMMUNICATIONS (2019)
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
Vitor Teixeira et al.
RMD OPEN (2019)
Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review
Nikolaos Tsetsos et al.
RHINOLOGY (2018)
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis
Giacomo Emmi et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
M. E. Wechsler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors A Randomized, Controlled Trial
Xavier Puechal et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis
Jens Thiel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study
Aikaterini Detoraki et al.
JOURNAL OF ASTHMA (2016)
Dividing the Janus vasculitis? Pathophysiology of eosinophilic granulomatosis with polyangitis
Benjamin Chaigne et al.
AUTOIMMUNITY REVIEWS (2016)
Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients
Marie Jachiet et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
A. J. Mohammad et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management
Matthieu Groh et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis
M. R. Hazebroek et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty-Five Years or Older
Christian Pagnoux et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Omalizumab: A Review of Its Use in Patients with Chronic Spontaneous Urticaria
Paul L. McCormack
DRUGS (2014)
Innate immunity in the lung regulates the development of asthma
Rosemarie H. DeKruyff et al.
IMMUNOLOGICAL REVIEWS (2014)
A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan
Ken-Ei Sada et al.
MODERN RHEUMATOLOGY (2014)
Impact of rituximab trials on the treatment of ANCA-associated vasculitis
Federico Alberici et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
L. Guillevin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients
Pierre Charles et al.
RHEUMATOLOGY (2014)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort
Cloe Comarmond et al.
ARTHRITIS AND RHEUMATISM (2013)
Omalizumab: A Review of its Use in Patients with Severe Persistent Allergic Asthma
Kate McKeage
DRUGS (2013)
Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials
Maxime Samson et al.
JOURNAL OF AUTOIMMUNITY (2013)
Decreases in the Numbers of Peripheral Blood Regulatory T Cells, and Increases in the Levels of Memory and Activated B Cells, in Patients with Active Eosinophilic Granulomatosis and Polyangiitis
Naomi Tsurikisawa et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear
Michael Walsh et al.
KIDNEY INTERNATIONAL (2013)
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
Lorraine Harper et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
IgG4 immune response in Churg-Strauss syndrome
Augusto Vaglio et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients
Bogdan Jakiela et al.
RHEUMATOLOGY (2012)
Targeting Interleukin-5 in Refractory and Relapsing Churg-Strauss Syndrome
Frank Moosig et al.
ANNALS OF INTERNAL MEDICINE (2011)
Multimodality Assessment of Cardiac Involvement in Churg-Strauss Syndrome Patients in Clinical Remission
Wojciech Szczeklik et al.
CIRCULATION JOURNAL (2011)
New pathophysiological insights and treatment of ANCA-associated vasculitis
Benjamin Wilde et al.
KIDNEY INTERNATIONAL (2011)
The Five-Factor Score Revisited Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort
Loic Guillevin et al.
MEDICINE (2011)
Cardiac Involvement in Churg-Strauss Syndrome
Robert M. Dennert et al.
ARTHRITIS AND RHEUMATISM (2010)
Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Controlled Trial
Thomas F. Hiemstra et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Sustained response to mepolizumab in refractory Churg-Strauss syndrome
Jean-Emmanuel Kahn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
Sophia Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
Rachel B. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial
Kirsten de Groot et al.
ANNALS OF INTERNAL MEDICINE (2009)
Churg-Strauss Syndrome in Patients Treated With Omalizumab
Michael E. Wechsler et al.
CHEST (2009)
Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome
Bogdan Jakiela et al.
RHEUMATOLOGY (2009)
Treatment of Churg-Strauss syndrome without poor-prognosis factors
Camillo Ribi et al.
ARTHRITIS AND RHEUMATISM (2008)
Churg-Strauss syndrome associated with omalizumab
Xavier Puechal et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2008)
Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis.
Christian Pagnoux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Omalizumab treatment associated with Churg-Strauss vasculitis
Elena Bargagli et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)
Randomized trial of plasma exchange or high-dosage Methylprednisolone as adjunctive therapy for severe renal vasculitis
David R. W. Jayne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Churg-Strauss syndrome with poor-prognosis factors:: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients
Pascal Cohen et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
B cell-targeted therapy for rheumatoid arthritis - An update on the evidence
R. John Looney
DRUGS (2006)
Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome
RA Sinico et al.
ARTHRITIS AND RHEUMATISM (2005)
Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000:: A capture-recapture estimate
A Mahr et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome
MG Danieli et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
分享论文
